You just read:

Kyowa Kirin Announces Mogamulizumab Received Positive CHMP Opinion for the Treatment of Mycosis Fungoides and Sézary Syndrome

News provided by

Kyowa Kirin International

21 Sep, 2018, 12:00 BST